COVID-19 Pandemic Impact on Delays in Diagnosis and Treatment for Cervical Cancer in Montreal, Canada.

IF 2.8 4区 医学 Q2 ONCOLOGY
Yohan Kerbage, Elise Hillmann, Jessica Ruel-Laliberté, Vanessa Samouelian
{"title":"COVID-19 Pandemic Impact on Delays in Diagnosis and Treatment for Cervical Cancer in Montreal, Canada.","authors":"Yohan Kerbage, Elise Hillmann, Jessica Ruel-Laliberté, Vanessa Samouelian","doi":"10.3390/curroncol32030147","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 pandemic has been responsible for a major reorganization of healthcare systems, with less access for cancer screening. Few data exist on the impact of cervical cancer treatment during the pandemic.</p><p><strong>Methods: </strong>The purpose of this study was to compare the cervical cancer stage at diagnosis and the surgical and medical treatment delays before and during the COVID-19 pandemic. This is a retrospective cohort study of all cervical cancers diagnosed at any stages between 1 January 2018 and 28 February 2022 at the Centre Hospitalier de l'Université de Montréal. Stage at diagnosis, time to initial referral, time from diagnosis to treatment before and during the COVID-19 pandemic were compared.</p><p><strong>Results: </strong>A total of 244 cervical cancers were diagnosed during the study period. No differences were observed between the number of cases diagnosed before and after pandemic (<i>p</i> = 0.237). Most patients and disease characteristics did not differ between the study periods, but the patients were significantly younger (<i>p</i> = 0.007), with higher BMI (<i>p</i> = 0.024) in the pandemic period. The mean time between initial diagnosis and referral was longer during the pandemic by 13 days (<i>p</i> = 0.042). The mean time between diagnosis and MRI and diagnosis and PET CT was not longer during the pandemic (<i>p</i> = 0.481 and <i>p</i> = 0.384). There were no significant differences in the mean time from the initial referring to the first visit at the CHUM (<i>p</i> = 0.895) or in the mean time from diagnosis to treatment (0.668) and duration of treatment (<i>p</i> = 0.181) Conclusion. Minor delays were observed during the COVID-19 pandemic. Cervical cancer patients treated at the CHUM, a tertiary and quaternary Canadian public health center, were globally referred and treated similarly, as those who were treated before pandemic.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"32 3","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11941124/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/curroncol32030147","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The COVID-19 pandemic has been responsible for a major reorganization of healthcare systems, with less access for cancer screening. Few data exist on the impact of cervical cancer treatment during the pandemic.

Methods: The purpose of this study was to compare the cervical cancer stage at diagnosis and the surgical and medical treatment delays before and during the COVID-19 pandemic. This is a retrospective cohort study of all cervical cancers diagnosed at any stages between 1 January 2018 and 28 February 2022 at the Centre Hospitalier de l'Université de Montréal. Stage at diagnosis, time to initial referral, time from diagnosis to treatment before and during the COVID-19 pandemic were compared.

Results: A total of 244 cervical cancers were diagnosed during the study period. No differences were observed between the number of cases diagnosed before and after pandemic (p = 0.237). Most patients and disease characteristics did not differ between the study periods, but the patients were significantly younger (p = 0.007), with higher BMI (p = 0.024) in the pandemic period. The mean time between initial diagnosis and referral was longer during the pandemic by 13 days (p = 0.042). The mean time between diagnosis and MRI and diagnosis and PET CT was not longer during the pandemic (p = 0.481 and p = 0.384). There were no significant differences in the mean time from the initial referring to the first visit at the CHUM (p = 0.895) or in the mean time from diagnosis to treatment (0.668) and duration of treatment (p = 0.181) Conclusion. Minor delays were observed during the COVID-19 pandemic. Cervical cancer patients treated at the CHUM, a tertiary and quaternary Canadian public health center, were globally referred and treated similarly, as those who were treated before pandemic.

简介COVID-19 大流行导致了医疗系统的重大重组,减少了癌症筛查的机会。有关大流行期间宫颈癌治疗影响的数据很少:本研究的目的是比较 COVID-19 大流行之前和期间宫颈癌的诊断阶段以及手术和药物治疗的延迟情况。这是一项回顾性队列研究,研究对象为2018年1月1日至2022年2月28日期间在蒙特利尔大学医院中心确诊的所有宫颈癌的任何阶段。研究比较了COVID-19大流行之前和期间的诊断分期、初始转诊时间、从诊断到治疗的时间:结果:研究期间共诊断出 244 例宫颈癌。大流行前后确诊的病例数没有差异(P = 0.237)。大部分患者和疾病特征在研究期间没有差异,但大流行期间的患者明显更年轻(p = 0.007),体重指数更高(p = 0.024)。在大流行期间,从初步诊断到转诊的平均时间延长了 13 天(p = 0.042)。大流行期间,诊断与核磁共振成像之间以及诊断与 PET CT 之间的平均时间并没有延长(p = 0.481 和 p = 0.384)。从初次转诊到首次到社区医疗中心就诊的平均时间(p = 0.895),以及从诊断到治疗的平均时间(0.668)和治疗持续时间(p = 0.181)均无明显差异。在 COVID-19 大流行期间出现了轻微的延误。在加拿大三级和四级公共卫生中心 CHUM 接受治疗的宫颈癌患者与大流行前接受治疗的患者一样,在全球范围内接受转诊和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current oncology
Current oncology ONCOLOGY-
CiteScore
3.30
自引率
7.70%
发文量
664
审稿时长
1 months
期刊介绍: Current Oncology is a peer-reviewed, Canadian-based and internationally respected journal. Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy in Canada to report upon and to review progress in the management of this disease. We encourage submissions from all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信